Swapnroop Drugs & Pharmaceuticals supports Mepolizumab API and biologic pharmaceutical raw material supply enquiries in India, serving pharmaceutical, biotechnology and research-related requirements.
Mepolizumab is a humanized monoclonal antibody developed to target interleukin-5 (IL-5). As a biologic pharmaceutical substance, its sourcing, handling, storage and documentation requirements differ from those of conventional small-molecule APIs.
We focus on reliable pharmaceutical sourcing, customer-specific documentation support, controlled supply coordination and professional assistance for biologic product enquiries.
Mepolizumab is an anti-interleukin-5 monoclonal antibody associated with eosinophilic disease therapies and biologic pharmaceutical research.
Key Applications:
Swapnroop Drugs & Pharmaceuticals supports Mepolizumab API and biologic drug substance enquiries from pharmaceutical companies, biotechnology organizations, research institutions, authorized distributors and international pharmaceutical buyers.
Our location in Chhatrapati Sambhajinagar (Aurangabad), Maharashtra, India supports pharmaceutical supply coordination and international customer requirements.
We support Mepolizumab API enquiries from pharmaceutical and biotechnology customers across India and international markets.
Our team assists customers with product availability enquiries, specifications, COA requirements, packaging information, commercial quotations and applicable supply documentation.
Biologic product supply is subject to product availability, customer verification, intended end-use requirements and applicable regulatory conditions.
Company: Swapnroop Drugs & Pharmaceuticals
Location: Chhatrapati Sambhajinagar (Aurangabad), Maharashtra, India
Email: enquiry@sdp.org.in
Website: www.sdp.org.in